Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
CLA3884 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A23236 | 23933265 | J Hepatol | Industrial, not fruit fructose intake is associated with the severity of liver fibrosis in genotype 1 chronic hepatitis C patients. | 2013 | Details |
| A23238 | 23932529 | Psychosomatics | Increased risk of chronic liver disease in patients with schizophrenia: a population-based cohort study. | 2013 | Details |
| A23250 | 23927644 | Eur J Clin Invest | Intrahepatic cholestasis in common chronic liver diseases. | 2013 | Details |
| A23252 | 23924495 | Hepatobiliary Pancreat Dis Int | Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C. | 2013 | Details |
| A23263 | 23919592 | BMC Pediatr | Intra-abdominal fat is related to metabolic syndrome and non-alcoholic fat liver disease in obese youth. | 2013 | Details |
| A23266 | 23915136 | Thyroid | Thyroid hormone analogues: where do we stand in 2013? | 2013 | Details |
| A23269 | 23913732 | Obesity (Silver Spring) | Comparison of in vivo effects of insulin on SREBP-1c activation and INSIG-1/2 in rat liver and human and rat adipose tissue. | 2013 | Details |
| A23302 | 23884827 | Eur Rev Med Pharmacol Sci | Role of insulin resistance and adipocytokines on serum alanine aminotransferase in obese patients with type 2 diabetes mellitus. | 2013 | Details |
| A23309 | 23875831 | BMC Gastroenterol | The FLS (fatty liver Shionogi) mouse reveals local expressions of lipocalin-2, CXCL1 and CXCL9 in the liver with non-alcoholic steatohepatitis. | 2013 | Details |
| A23322 | 23871755 | Free Radic Biol Med | MicroRNA modulation of lipid metabolism and oxidative stress in cardiometabolic diseases. | 2013 | Details |
| A23357 | 23844815 | Curr Pharm Des | Nonalcoholic fatty liver disease and cardiovascular disease. | 2014 | Details |
| A23370 | 23837136 | Clin Mol Hepatol | Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease. | 2013 | Details |
| A23379 | 23832548 | Hepatology | M2 Kupffer cells promote M1 Kupffer cell apoptosis: a protective mechanism against alcoholic and nonalcoholic fatty liver disease. | 2013 | Details |
| A23382 | 23830602 | Acad Radiol | MR fat fraction mapping: a simple biomarker for liver steatosis quantification in nonalcoholic fatty liver disease patients. | 2013 | Details |
| A23384 | 23829392 | BMC Cancer | Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma. | 2013 | Details |
| A23417 | 23801829 | World J Gastroenterol | What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? | 2013 | Details |
| A23421 | 23798362 | J Hepatobiliary Pancreat Sci | Effects of pancrelipase on nonalcoholic fatty liver disease after pancreaticoduodenectomy. | 2013 | Details |
| A23422 | 23798324 | Liver Transpl | Liver transplantation with a strongly positive crossmatch: case study and literature review. | 2013 | Details |
| A23426 | 23792031 | J Hepatol | The role of hepassocin in the development of non-alcoholic fatty liver disease. | 2013 | Details |
| A23463 | 23758436 | Clin Sci (Lond) | Impact of PPAR-α induction on glucose homoeostasis in alcohol-fed mice. | 2013 | Details |
| A23473 | 23747427 | Toxicol Lett | Impairment of reproductive function in a male rat model of non-alcoholic fatty liver disease and beneficial effect of N-3 fatty acid supplementation. | 2013 | Details |
| A23494 | 23730487 | Korean J Fam Med | Non-alcoholic Fatty Liver Disease and Chronic Kidney Disease in Koreans Aged 50 Years or Older. | 2013 | Details |
| A23496 | 23727264 | Gastroenterology | Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. | 2013 | Details |
| A23525 | 23707549 | Pathol Res Pract | Presence and extent of estrogen receptor-alpha expression in patients with simple steatosis and NASH. | 2013 | Details |
| A23539 | 23700488 | PLoS One | Ageing Fxr deficient mice develop increased energy expenditure, improved glucose control and liver damage resembling NASH. | 2013 | Details |
| A23540 | 23698776 | Int J Mol Sci | Obesity-associated oxidative stress: strategies finalized to improve redox state. | 2013 | Details |
| A23553 | 23688034 | BMC Med Genet | Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C > G) in the development of fatty liver. | 2013 | Details |
| A23566 | 23669283 | J Hepatol | NKT-cell subsets: promoters and protectors in inflammatory liver disease. | 2013 | Details |
| A23575 | 23663766 | Zhonghua Gan Zang Bing Za Zhi | [Risk factors analysis of nonalcoholic fatty liver disease in Chinese men]. | 2013 | Details |
| A23586 | 23656177 | Liver Int | Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up. | 2013 | Details |
| A23598 | 23643404 | Metabolism | Liver enzymes and vitamin D levels in metabolically healthy but obese individuals: Korean National Health and Nutrition Examination Survey. | 2013 | Details |
| A23601 | 23638085 | PLoS One | Novel algorithm for non-invasive assessment of fibrosis in NAFLD. | 2013 | Details |
| A23611 | 23627007 | Crit Rev Immunol | Role of scavenger receptors in the pathophysiology of chronic liver diseases. | 2013 | Details |
| A23613 | 23626730 | PLoS One | Influence of non-alcoholic fatty liver disease on autonomic changes evaluated by the time domain, frequency domain, and symbolic dynamics of heart rate variability. | 2013 | Details |
| A23614 | 23626003 | J Clin Endocrinol Metab | Circulating levels of FGF-21 in obese youth: associations with liver fat content and markers of liver damage. | 2013 | Details |
| A23623 | 23619824 | Cell Biol Int | Correlation analysis between gene expression profile of high-fat emulsion-induced non-alcoholic fatty liver and liver regeneration in rat. | 2013 | Details |
| A23624 | 23619258 | Ann Hepatol | Validation study of systems for noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in Latin population. | 2013 | Details |
| A23651 | 23597726 | Gastroenterology | Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals. | 2013 | Details |
| A23656 | 23593497 | PLoS One | Neuroendocrine regulation and metabolism of glucose and lipids in primary chronic insomnia: a prospective case-control study. | 2013 | Details |
| A23673 | 23577962 | J Gastroenterol Hepatol | Severity of non-alcoholic steatohepatitis is associated with substitution of adipose tissue in skeletal muscle. | 2013 | Details |
| A23694 | 23560443 | Int J Exp Pathol | Inhibition of Glutaminyl Cyclases alleviates CCL2-mediated inflammation of non-alcoholic fatty liver disease in mice. | 2013 | Details |
| A23701 | 23555578 | PLoS One | NIKEI: a new inexpensive and non-invasive scoring system to exclude advanced fibrosis in patients with NAFLD. | 2013 | Details |
| A23736 | 23519653 | Hepatol Int | Hepatic angiogenesis and fibrosis are common features in morbidly obese patients. | 2011 | Details |
| A23741 | 23516571 | PLoS One | Systems biology elucidates common pathogenic mechanisms between nonalcoholic and alcoholic-fatty liver disease. | 2013 | Details |
| A23742 | 23516172 | World J Gastrointest Pharmacol Ther | Inhibition of apoptosis in the management of nonalcoholic fatty liver disease. | 2013 | Details |
| A23753 | 23510093 | Hepatol Res | Novel effect of ezetimibe to inhibit the development of non-alcoholic fatty liver disease in Fatty Liver Shionogi mouse. | 2013 | Details |
| A23763 | 23504926 | Hepatology | Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). | 2013 | Details |
| A23770 | 23497552 | BMC Res Notes | Morphological and metabolic determinants of nonalcoholic fatty liver disease in obese youth: a pilot study. | 2013 | Details |
| A23778 | 23488792 | J Gastroenterol Hepatol | Antigen peptide transporter 1 is involved in the development of fructose-induced hepatic steatosis in mice. | 2013 | Details |
| A23781 | 23485520 | J Hepatol | The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease. | 2013 | Details |
| A23784 | 23482703 | World J Gastroenterol | NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients. | 2013 | Details |
| A23817 | 23451176 | PLoS One | Differential intrahepatic phospholipid zonation in simple steatosis and nonalcoholic steatohepatitis. | 2013 | Details |
| A23828 | 23442837 | J Clin Gastroenterol | Stepwise combination of simple noninvasive fibrosis scoring systems increases diagnostic accuracy in nonalcoholic fatty liver disease. | 2013 | Details |
| A23855 | 23426271 | Eur J Gastroenterol Hepatol | Alcoholic liver disease/nonalcoholic fatty liver disease index: distinguishing alcoholic from nonalcoholic fatty liver disease. | 2013 | Details |
| A23873 | 23415456 | Nutr Metab Cardiovasc Dis | Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. | 2013 | Details |
| A23892 | 23398788 | Arch Med Res | Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: a 4-year longitudinal study. | 2013 | Details |
| A23904 | 23394096 | Curr Pharm Des | Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD. | 2013 | Details |
| A23906 | 23394094 | Curr Pharm Des | Antioxidant therapy and drugs interfering with lipid metabolism: could they be effective in NAFLD patients? | 2013 | Details |
| A23909 | 23394091 | Curr Pharm Des | Epidemiology and natural history of patients with NAFLD. | 2013 | Details |
| A23910 | 23394090 | Curr Pharm Des | Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease. | 2013 | Details |
| A23914 | 23391614 | Toxicol Appl Pharmacol | Decreased hepatotoxic bile acid composition and altered synthesis in progressive human nonalcoholic fatty liver disease. | 2013 | Details |
| A23915 | 23390894 | Atherosclerosis | The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study. | 2013 | Details |
| A23924 | 23385644 | J Mol Med (Berl) | Lack of kinin B₁ receptor potentiates leptin action in the liver. | 2013 | Details |
| A23947 | 27785221 | Gastroenterology Res | Association Between Appendectomy and Fibrosis Progression in Nonalcoholic Fatty Liver Disease. | 2013 | Details |
| A23950 | 23356584 | Liver Int | Heterogeneity of fibrosis patterns in non-alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways. | 2013 | Details |
| A23969 | 23340336 | Br J Nutr | Carbohydrate quality is not associated with liver enzyme activity and plasma TAG and HDL concentrations over 5 years in an older population. | 2013 | Details |
| A23985 | 23326306 | PLoS One | Non-alcoholic fatty liver disease is closely associated with sub-clinical inflammation: a case-control study on Asian Indians in North India. | 2013 | Details |
| A23990 | 23320802 | Alcohol Clin Exp Res | Hepatic and extrahepatic malignancies in cirrhosis caused by nonalcoholic steatohepatitis and alcoholic liver disease. | 2013 | Details |
| A23994 | 23320150 | J Obes | Nonalcoholic fatty liver disease and cardiovascular disease: has the time come for cardiologists to be hepatologists? | 2012 | Details |
| A24000 | 23315648 | Z Gastroenterol | Non-alcoholic steatohepatitis occurs in celiac disease and is associated with cellular stress. | 2013 | Details |
| A24001 | 23313470 | Prostaglandins Leukot Essent Fatty Acids | Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids. | 2013 | Details |
| A24029 | 23294790 | J Diabetes Sci Technol | A simple Indian diabetes risk score could help identify nondiabetic individuals at high risk of non-alcoholic fatty liver disease (CURES-117). | 2012 | Details |
| A24047 | 23283181 | Curr Opin Gastroenterol | Dietary treatment of nonalcoholic steatohepatitis. | 2013 | Details |
| A24052 | 23278163 | Aliment Pharmacol Ther | Review article: the diagnosis of non-alcoholic fatty liver disease -- availability and accuracy of non-invasive methods. | 2012 | Details |
| A24057 | 23272512 | Rev Med Chir Soc Med Nat Iasi | Non-alcoholic fatty liver disease is associated with cardiovascular risk factors of metabolic syndrome. | 2013 | Details |
| A24120 | 23212097 | Lab Invest | Spontaneous onset of nonalcoholic steatohepatitis and hepatocellular carcinoma in a mouse model of metabolic syndrome. | 2012 | Details |
| A24129 | 23201248 | J Hepatol | Stage of change and motivation to healthier lifestyle in non-alcoholic fatty liver disease. | 2012 | Details |
| A24138 | 23188092 | J Gastroenterol | Oral contraceptive pill use is associated with reduced odds of nonalcoholic fatty liver disease in menstruating women: results from NHANES III. | 2012 | Details |
| A24143 | 23183525 | J Hepatol | Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal. | 2012 | Details |
| A24151 | 23176674 | BMC Med Genet | Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population. | 2012 | Details |
| A24152 | 23175777 | J Lipid Res | Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat. | 2012 | Details |
| A24158 | 23172799 | J Magn Reson Imaging | Reproducibility of hepatic fat fraction measurement by magnetic resonance imaging. | 2012 | Details |
| A24168 | 23158405 | J Surg Res | Lysophospholipid variants in hepatocellular carcinoma. | 2012 | Details |
| A24172 | 23154483 | J Pediatr Gastroenterol Nutr | Levels of serum ceruloplasmin associate with pediatric nonalcoholic fatty liver disease. | 2013 | Details |
| A24175 | 23147992 | Br J Surg | Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome. | 2012 | Details |
| A24178 | 23144979 | PLoS One | The A736V TMPRSS6 polymorphism influences hepatic iron overload in nonalcoholic fatty liver disease. | 2012 | Details |
| A24200 | 23127599 | Food Chem Toxicol | Alleviative effects of resveratrol on nonalcoholic fatty liver disease are associated with up regulation of hepatic low density lipoprotein receptor and scavenger receptor class B type I gene expressions in rats. | 2012 | Details |
| A24221 | 23108307 | Dig Dis | Adipocytokines and hepatocellular carcinoma. | 2012 | Details |
| A24230 | 23075870 | Dig Dis | Nonalcoholic fatty liver disease: what the pathologist can tell the clinician. | 2012 | Details |
| A24234 | 23091812 | Clin Mol Hepatol | Type and cause of liver disease in Korea: single-center experience, 2005-2010. | 2012 | Details |
| A24235 | 23091808 | Clin Mol Hepatol | Enhanced A-FABP expression in visceral fat: potential contributor to the progression of NASH. | 2012 | Details |
| A24242 | 23085008 | Biochim Biophys Acta | Dietary eicosapentaenoic acid supplementation accentuates hepatic triglyceride accumulation in mice with impaired fatty acid oxidation capacity. | 2012 | Details |
| A24249 | 23077135 | Gut | Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease. | 2012 | Details |
| A24256 | 23070083 | J Physiol Pharmacol | A novel pathophysiological-based panel of biomarkers for the diagnosis of nonalcoholic steatohepatitis. | 2012 | Details |
| A24267 | 23063693 | Biochimie | A systems biology approach to the hepatic role of the oxysterol receptor LXR in the regulation of lipogenesis highlights a cross-talk with PPARα. | 2012 | Details |
| A24270 | 23062376 | Ultrasound Med Biol | Ex vivo study of quantitative ultrasound parameters in fatty rabbit livers. | 2012 | Details |
| A24276 | 23055155 | Hepatology | Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. | 2013 | Details |
| A24284 | 23040432 | Can J Cardiol | Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents. | 2012 | Details |
| A24292 | 23032985 | Am J Gastroenterol | The interaction of rs738409, obesity, and alcohol: a population-based autopsy study. | 2012 | Details |
| A24323 | 22999011 | Metabolism | In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not. | 2012 | Details |